|
Volumn 47, Issue 3, 1999, Pages 279-281
|
Continuous radiosensitizing chemotherapy;Chimiotherapies continues a visee radiosensibilisante
a a |
Author keywords
5FU; Head and neck cancer; Lung cancer; Radiochemotherapy; Rectal cancer
|
Indexed keywords
CISPLATIN;
ETOPOSIDE;
FLUOROURACIL;
RADIOSENSITIZING AGENT;
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CENTRAL VENOUS CATHETERIZATION;
CONFERENCE PAPER;
ESOPHAGUS CANCER;
HEAD AND NECK CANCER;
HUMAN;
LUNG CANCER;
NUTRITIONAL SUPPORT;
PARENTERAL NUTRITION;
RADIOSENSITIZATION;
TREATMENT INDICATION;
VASCULAR ACCESS;
CARCINOMA;
CLINICAL TRIAL;
HEAD AND NECK TUMOR;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG TUMOR;
MULTIMODALITY CANCER THERAPY;
RECTUM TUMOR;
REVIEW;
ANTINEOPLASTIC AGENTS;
CARBOPLATIN;
CARCINOMA;
CISPLATIN;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
ETOPOSIDE;
FLUOROURACIL;
HEAD AND NECK NEOPLASMS;
HUMANS;
INFUSIONS, INTRAVENOUS;
LUNG NEOPLASMS;
NUTRITIONAL SUPPORT;
RADIATION-SENSITIZING AGENTS;
RECTAL NEOPLASMS;
|
EID: 0032894555
PISSN: 03698114
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (2)
|
References (12)
|